On 24 November 2025, Novo Nordisk reported that oral semaglutide had failed to slow Alzheimers disease in the EVOKE and EVOKE+ trials, which together enrolled 3,808 participants and stand as the largest evaluation of this drug class in any neurodegenerative condition [1]
It evens out skin tone and fades dark spots
The slowed gastric emptying that contributes to satiety and weight loss can delay intestinal transit time, potentially leading to harder stools and difficulty with bowel movements
A diferencia de los medicamentos inyectables como semaglutida o liraglutida, estos probiticos buscan modular el microbioma intestinal para potencialmente aumentar la secrecin endgena de esta hormona metablica
Developed as part of a group of drugs called GLP-1 receptor agonists, semaglutide works in specific ways in the body to help people control their blood sugar levels, manage their weight, and even reduce certain risks associated with type 2 diabetes, such as heart disease
Perhaps the most important first step a patient can take is to have the diagnosis made
:max_bytes(150000):strip_icc():focal(748x241:750x243)/Serena-Williams-1-012726-2698f17c5ab647929a79194c436d85ea.jpg)
